Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Minocycline is a semisynthetic second-generation tetracycline derivative, and many publications provide evidence of its successful neuroprotection in a variety of animal models. We searched PubMed and Chinese CNKI databases from January 1992 to May 2012 for studies on minocycline in neurodegenerative diseases in rodents. A meta-analysis that adopted weighted Cohen’s d effect sizes, percent overlap, Fail-Safe N statistics, and confidence intervals was conducted. In total, 16 English and 3 Chinese articles with high or medium quality were included in this meta-analysis. The treatment benefits for rodents from low-dose (5 mg/kg/day), moderate-dose (45, 50, or 55 mg/kg/day), and high-dose (90 mg/kg/day) minocycline were larger in Huntington’s disease, Alzheimer’s disease, and stroke mouse models, respectively. In rats, a moderate dose (45 mg/kg/day) of minocycline was most effective. In conclusion, minocycline exerts neuroprotective effects in rodent models of neurodegenerative diseases. Anti-inflammatory, antiapoptotic, and antioxidant activities are discussed as the basis of this effect. However, there is insufficient information from these animal models on side effects of minocycline therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zakzanis, K. K. (2001) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/16.7.653 · Cited by 346 · cited 2×
“…(1) where SDpooled was calculated using Equation (2): SDpooled = {[(N1-1) SD12+(N2-1) SD22]/(N1+N2-2)}1/2 (2) However, in some other studies, means and SDs were not expressed, and t values, F values, or exact p values were transformed to d according to the formula provided by Zakzanis (2001).”
BackgroundMethodDeleterious Effects of Minocycline in Animal Models of Parkinson’s Disease and Huntington’s Disease
Diguet, E., Fernagut, P., Wei, X., Du, Y., Rouland, R., Gross, C., Bezard, E., & Tison, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03372.x · Cited by 189
Minocycline Enhances MPTP Toxicity to Dopaminergic Neurons
Yang, L., Sugama, S., Chirichigno, J. W., Gregorio, J., Lorenzl, S., Shin, D. H., Browne, S. E., Shimizu, Y., Joh, T. H., Beal, M. F., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10709 · Cited by 158 · cited 1×
“The clinical features of PD include a resting tremor, bradykinesia, stooped posture, shuffling gait, difficulty swallowing, and rigidity in the extremities accompanied by a loss in control of fine movements (Yang et al., 2003).”
BackgroundClinical Potential of Minocycline for Neurodegenerative Disorders
BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157 · cited 1×
“Thus, minocycline has been reported to provide neuroprotection and reduce brain degeneration in models of neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and stroke (Blum et al., 2004; Noble et al., 2009).”
BackgroundLin, S., Wei, X., Xu, Y., Yan, C., Dodel, R., Zhang, Y., Liu, J., Klaunig, J. E., Farlow, M., & Du, Y. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02442-6 · Cited by 70 · cited 1×
“In addition, minocycline could protect neurons against neurotoxicity by inhabiting MPTP and 6-hydroxydopamine (6-OHDA)-induced free radical generation (Lin et al., 2003).”
Background
Cited by
Inflammation in neurodegenerative diseases—An update
Amor, S., Peferoen, L. A. N., Vogel, D. Y. S., Breur, M., van der Valk, P., Baker, D., & van Noort, J. M. (2014) · Immunology · doi:10.1111/imm.12233 · Cited by 550
Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Decourt, B., Lahiri, D. K., & Sabbagh, M. N. (2017) · Current Alzheimer Research · doi:10.2174/1567205013666160930110551 · Cited by 371
Health-promoting effects of the citrus flavanone hesperidin
Li, C., & Schluesener, H. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.906382 · Cited by 357
Self-citationAntibiotics and the nervous system: More than just the microbes?
Champagne-Jorgensen, K., Kunze, W. A., Forsythe, P., Bienenstock, J., & McVey Neufeld, K.-A. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.12.014 · Cited by 92
Challenges of Repurposing Tetracyclines for the Treatment of Alzheimer’s and Parkinson’s Disease
Markulin, I., Matasin, M., Turk, V. E., & Salković-Petrisic, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02457-2 · Cited by 36
“However, literature data outside of the meta-analysis of Li and coworkers (Li et al. 2013) demonstrated that short-term treatment with a low minocycline dose (10 mg/kg i.”
Background
Metadata
- Authors
- Li, C., Yuan, K., & Schluesener, H.
- Venue
- revneuro
- Publisher
- Walter de Gruyter GmbH
- Published
- 2013-09-28
- Volume
- 24
- Issue
- 5
- Pages
- 553-562
- ISSN
- 0334-1763 (ISSN-L)
- 2191-0200
- OpenAlex
- W2055651600
- Cited by
- 50
- References
- 5
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis. https://app.cochat.ai/papers/10.1515/revneuro-2013-0040
- The paper
- Li, C., Yuan, K., & Schluesener, H. (2013). Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis. revneuro. https://doi.org/10.1515/revneuro-2013-0040
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.